Identifying Cancer-Specific Proteins Using Next-Gen Protein Sequencing™

Case Study

“While mass spectrometry is a powerful tool for proteomics, it has limitations. We see Quantum-Si’s Platinum® technology as an approach that could enhance our ability to identify cancer-specific proteins, ultimately making our research more efficient.” — Glenn Gregorio, PhD

Explore this case study to see how Sanavia Oncology’s interest in Next-Gen Protein Sequencing™ (NGPS™) using the Quantum-Si’s Platinum® instrument stems from their need to better characterize novel cancer targets, and why they see it as a crucial tool in their target identification workflow.

"*" indicates required fields

Learn More about Platinum® Protein Sequencing Technology

Please fill out this form to access the resource.

First Name*

Last Name*

Organization Name*

Email*

Phone

Country*

State*

Zip Code*

Province*

Industry*

Primary Protein Sequencing Application*

Additional Assistance

Message